CORRECTION article
Front. Cell Dev. Biol.
Sec. Cell Death and Survival
Volume 13 - 2025 | doi: 10.3389/fcell.2025.1685448
Correction:[Cooperative targeting of NF-κB enhances ferroptosis-driven HCC therapy with Alisertib and Donafenib]
Provisionally accepted- Nanjing University, Nanjing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Frontiers' correction template for authors A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval. Instructions: ● Please read through all the templates before choosing ● Pick the most relevant text template(s) from the following page and delete all others. ● Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. ● Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary ● Submit to Frontiers following the instructions on this page. When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example: There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake. The original version of this article has been updated. In the published article, there was a mistake in the Funding statement. The funding statement for the Key Development Project of the Department of Science and Technology was displayed as "2015CBd051". The correct statement is "Key Development Project of Department of Science and Technology (2015C03Bd051).'' Template continues on the next page There was a mistake in figure [3I] as published. [During the proofing process, the image intended to represent the p65 WB bands from Huh7 cells was mistakenly duplicated, which resulted in the appearance of incorrect images in Figure 3I. We have since conducted a thorough review of all original bands and have confirmed that the original images were accurate and did not contain any duplication. This error was unintentional and occurred during the image compilation. Importantly, this correction does not affect the conclusions drawn from our experiments. ]. The corrected figure [3] appears below. The original version of this article has been updated. End of template. If you would like to request a correction for a reason not seen here, please contact the journal's editorial office.
Keywords: Hepatocellular Carcinoma, Donafenib, alisertib, ferroptosis, NF-κB signaling pathway
Received: 13 Aug 2025; Accepted: 27 Aug 2025.
Copyright: © 2025 Zhou and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Qiong Zhou, Nanjing University, Nanjing, China
Rui Wang, Nanjing University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.